Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.330
+0.040 (3.10%)
At close: Mar 6, 2026, 4:00 PM EST
1.340
+0.010 (0.75%)
After-hours: Mar 6, 2026, 4:11 PM EST
Pliant Therapeutics Employees
Pliant Therapeutics had 171 employees as of December 31, 2024. The number of employees increased by 13 or 8.23% compared to the previous year.
Employees
171
Change (1Y)
13
Growth (1Y)
8.23%
Revenue / Employee
n/a
Profits / Employee
-$1,026,310
Market Cap
81.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Adicet Bio | 152 |
| Seres Therapeutics | 103 |
| Fractyl Health | 101 |
| XBiotech | 88 |
| PolyPid | 73 |
| Verrica Pharmaceuticals | 71 |
| PMV Pharmaceuticals | 47 |
PLRX News
- 1 day ago - Stock Picks From Seeking Alpha's February 2026 New Analysts - Seeking Alpha
- 11 days ago - Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration - Seeking Alpha
- 12 days ago - Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference - GlobeNewsWire
- 3 months ago - Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors - Benzinga
- 3 months ago - Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 3 months ago - Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - GlobeNewsWire
- 4 months ago - Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 months ago - Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire